EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINE
- 1 May 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 309 (8019), 977-979
- https://doi.org/10.1016/s0140-6736(77)92279-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOADThe Lancet, 1976
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*Annals of the New York Academy of Sciences, 1974
- The Effect of Ascorbic Acid Deficiency on Desferrioxamine‐Induced Urinary Iron ExcretionBritish Journal of Haematology, 1969
- Effects of Iron Overload on Ascorbic Acid MetabolismBMJ, 1968
- Evaluation of storage iron by chelatesThe American Journal of Medicine, 1968
- Accelerated Oxidative Catabolism of Ascorbic Acid in Siderotic BantuThe American Journal of Clinical Nutrition, 1967
- Application of Atomic Absorption Spectrophotometry in the Determination of Iron in UrineAmerican Journal of Clinical Pathology, 1965
- Iron Metabolism in Scurvy with Special Reference to ErythropoiesisBritish Journal of Haematology, 1964